Bendamustine-Bortezomib-Dexametasone (BVD) in the Management of Relapsed and Refractory Multiple Myeloma: A Real-Life Experience
Keyword(s):
2014 ◽
Vol 23
(2)
◽
pp. 301-302
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):